Abbott Laboratories (ABT) vs Stryker Corporation (SYK)
Abbott Laboratories and Stryker Corporation are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $174.8B against $103.9B — 1.7× the size. Stryker Corporation trades at the lower P/E: 28.0× against 32.8×. Stryker Corporation grew revenue faster over the last twelve months: 8.48% against 8.06%. Stryker Corporation has the higher net margin (14.4% vs 11.7%) and the higher return on invested capital (9.76% vs 5.83%). Both pay a dividend; Abbott Laboratories yields more (1.88% vs 0.77%). Across the 23 metrics below, Stryker Corporation leads on 18 and Abbott Laboratories on 5.
Valuation
Profitability
| Metric | ABT | SYK | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.61% | 64.98% | 56.01% |
| Operating margin | 15.77% | 21.42% | (15.03%) |
| Net margin | 11.65% | 14.43% | (20.40%) |
| Free cash flow margin | 16.80% | 18.20% | (7.24%) |
| Return on equity | 10.58% | 16.51% | (15.32%) |
| Return on assets | 5.62% | 7.91% | (19.72%) |
| Return on invested capital | 5.83% | 9.76% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack